Tolak patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7169401 HILL DERMACEUTICALS Topical skin care composition containing refined peanut oil
Jul, 2023

(2 months ago)

Tolak is owned by Hill Dermaceuticals.

Tolak contains Fluorouracil.

Tolak has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Tolak are:

  • US7169401

Tolak was authorised for market use on 18 September, 2015.

Tolak is available in cream;topical dosage forms.

The generics of Tolak are possible to be released after 18 July, 2023.

Drugs and Companies using FLUOROURACIL ingredient

Market Authorisation Date: 18 September, 2015

Treatment: NA


More Information on Dosage

TOLAK family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic